Format

Send to

Choose Destination
Leukemia. 2014 Aug;28(8):1759-62. doi: 10.1038/leu.2014.116. Epub 2014 Mar 28.

Leukemic stem cells of acute myeloid leukemia patients carrying NPM1 mutation are candidates for targeted immunotherapy.

Author information

1
Department of Internal Medicine III, University of Ulm, Ulm, Germany.
2
1] Department of Internal Medicine III, University of Ulm, Ulm, Germany [2] Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
3
Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
4
Department of Pathology, University of Ulm, Ulm, Germany.
5
1] Department of Internal Medicine III, University of Ulm, Ulm, Germany [2] Department of Internal Medicine, Diakonie Hospital Stuttgart, Stuttgart, Germany.
PMID:
24675106
DOI:
10.1038/leu.2014.116
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center